Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dexloxiglumide Rotta Research Lab.

Gábor Varga1

  • 1Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest. varga-g@koki.hu

Current Opinion in Investigational Drugs (London, England : 2000)
|July 2, 2002
PubMed
Summary

Dexloxiglumide, a potent CCK1 receptor antagonist, effectively treats gastrointestinal disorders like IBS by improving gallbladder contraction, LES function, and gastric emptying. Clinical studies show significant symptom reduction in patients with functional dyspepsia and constipation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Splintless approach improves surgical accuracy in Le Fort I osteotomies: a systematic review and meta-analysis.

Frontiers in oral health·2026
Same author

Inclusivity in Oral Care: A Comprehensive Dental Prevention Approach to Improve Cooperation and Oral Hygiene in Children with Special Needs.

Journal of clinical medicine·2026
Same author

Tuneable electronic control of noble metal catalysis by polymeric supports.

Chemical communications (Cambridge, England)·2026
Same author

Complete denture soft liners improve bite force, mastication, and life quality: A systematic review and meta-analysis.

Journal of prosthodontics : official journal of the American College of Prosthodontists·2026
Same author

Functional model for amelogenesis: polarization and pH sensitivity of calcium uptake in ameloblast-derived HAT-7 cells.

Calcified tissue international·2026
Same author

Accuracy of Digital and Conventional Implant Impressions in Edentulous Jaws: A Systematic Review and Meta-Analysis of In Vitro Studies.

Dentistry journal·2026

Area of Science:

  • Pharmacology
  • Gastroenterology

Background:

  • Dexloxiglumide is the (R)-isomer of loxiglumide, a selective and potent CCK1 receptor antagonist.
  • CCK1 receptor activity is implicated in gastrointestinal motility, food intake, and pancreatic disorders.

Purpose of the Study:

  • To evaluate dexloxiglumide's efficacy in treating gastrointestinal disorders.
  • To assess its potential for managing constipation-predominant IBS and functional dyspepsia.

Main Methods:

  • In vitro and in vivo pharmacological systems were used to study receptor-mediated actions.
  • Preclinical and clinical studies were conducted to assess efficacy.

Main Results:

  • Dexloxiglumide effectively inhibits gallbladder contraction and improves lower esophageal sphincter (LES) function.
  • It accelerates gastric emptying, colonic transit, and significantly reduces symptoms in IBS and functional dyspepsia patients.

Conclusions:

  • Dexloxiglumide demonstrates potential as an effective treatment for constipation-predominant IBS, functional dyspepsia, and other related gastrointestinal disorders.
  • Phase III studies are ongoing for the treatment of constipation-predominant IBS.

Related Experiment Videos